Neurowyzr (Formerly Cognifyx)

NeuroWyzr operates in the brain health and cognitive performance sector, offering digital solutions aimed at early detection, diagnosis, therapy, monitoring, and prevention of brain decline. The company serves a diverse clientele including corporate sectors, healthcare providers, insurance companies, and pharmaceutical firms. NeuroWyzr's core products include the Digital Brain Function Scan, Attayn, Nhyre, and Attycus, which collectively contribute to optimizing personal brain potential and quality of life. The business model revolves around providing these digital tools and platforms to organizations that prioritize brain health and cognitive performance, thereby generating revenue through subscription fees, licensing, and service contracts. NeuroWyzr's market focus is primarily on regions where mental health issues are prevalent, such as the Asia Pacific, addressing the growing concern of cognitive decline and dementia. The company's innovative approach positions it as a key player in the emerging brain health industry.

Keywords: brain health, cognitive performance, early detection, digital solutions, therapy, monitoring, prevention, corporate sector, healthcare providers, brain decline.